标题 |
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial
根据老年AML患者的残留疾病状态加强氟达拉滨、AraC、G-CSF和伊达比星或克拉屈滨加柔红霉素和AraC的治疗:来自NCRI AML18试验的结果
|
网址 | |
DOI | |
求助人 | |
下载 |